摘要目的 全皮下植入型心律转复除颤器(S-ICD)是预防心脏性猝死的新方法,但在国内处于初期应用阶段.本文就国内12例S-ICD应用情况进行汇总分析.方法 连续纳入国内9家中心筛选并成功植入S-ICD的12例患者,分析其应用情况.结果 自2014年12月23日至2016年12月31日,全国9家中心共成功植入S-ICD 12例,男9例(75%),年龄35~78(51.9±15.5)岁,体质指数 20.8~30.7(25.3±3.6).手术时间70~120(93.3±18.7) min,术中测试除颤阻抗57~103(70±15.4) Ω,室性心律失常诱发后诊断至除颤成功时间为12~30(16.4±5.0) s.术中未发生严重并发症.结论 S-ICD是心律转复除颤器研发过程中一项新的技术,国内应用尚在起步阶段,现有资料证实其植入操作较顺利且无严重并发症.临床亟待其在适应人群的推广应用以及技术的不断完善.

abstractsObjective Subcutaneous implantable cardioverter defibrillator (S-ICD) is a new approach for the prevention of sudden cardiac death,but it is still in the early stage of application in China.In this study,we enrolled 12 cases of S-ICD implantation and made a summary and analysis.Methods Twelve patients from 9 heart centers were enrolled and successfully implanted with S-ICD in China.The application was analyzed.Results From December 23,2014 to December 31,2016,12 patients were successfully implanted in 9 heart centers.Among them,9 were males and 3 were females,the age were from 35 to 78 (51.9 ± 15.5) years old,the body mass indexes were 20.8-30.7 (25.3 ± 3.6).Surgery took about 70-120 (93.3 ± 18.7) minutes.Mean shock impedance was 57-103 (70 ± 15.4) Ω and time to therapy was 12-30 (16.4 ± 5.0) seconds.No serious complications occurred.Conclusion S-ICD is a new technique in the development of cardioverter defibrillator.The domestic application is still in the initial stage.The existing data indicates that the implantation operation is smooth and there is no serious complication.For the further clinical use,the related technologies need to constantly improve.